European Society for Radiotherapy and Oncology (ESTRO) shared a post on X:
“35 million patients treated.
Watch Part 1 of our interview with Breur Medal awardee Prof Thomas Bortfeld as he reflects on the staggering scale of MLC-based IMRT and how AI “optimal stopping” and biomarkers are set to redefine fractionation.”
Other articles about ESTRO on OncoDaily.